Therapy for chronic hepatitis B and C infection in haemophilia.
Haemophiliacs, until recently, have been at risk of hepatitis B and C infection. Substantial numbers of patients remain persistently infected. Several lines of evidence suggest that these diseases will cause considerable morbidity unless therapy can successfully reduce viraemia and prevent disease progression. Cessation of viral replication may prevent progression to hepatic fibrosis.
Dusheiko
G M
GM
Royal Free Hospital and School of Medicine, London, UK. gdusheiko@msn.com
D000998:Antiviral Agents / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications*; D002836:Hemophilia B / Q000150:complications*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000209:etiology; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000209:etiology; D006801:Humans
D000998:Antiviral Agents